AU Patent

AU2003299453A1 — Short-acting sedative hypnotic agents for anesthesia and sedation

Assigned to Theravance Biopharma R&D IP LLC · Expires 2004-05-13 · 22y expired

What this patent protects

The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals.

USPTO Abstract

The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals.

Drugs covered by this patent

Patent Metadata

Patent number: AU2003299453A1
Jurisdiction: AU
Classification: —
Expires: 2004-05-13
Drug substance claim: No
Drug product claim: No
Assignee: Theravance Biopharma R&D IP LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.